— Know what they know.
Not Investment Advice

EWTX NASDAQ

Edgewise Therapeutics, Inc.
1W: +3.3% 1M: -0.4% 3M: -2.9% YTD: +64.9% 1Y: +159.4% 3Y: +432.2% 5Y: +125.5%
$39.53
+0.36 (+0.92%)
After Hours: $38.52 (-1.01, -2.54%)
Weekly Expected Move ±5.6%
$35 $37 $39 $41 $44
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 44 · $4.2B mcap · 82M float · 1.69% daily turnover · Short 65% of daily vol
Credit Risk of going bust: lower than 83% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Edgewise Therapeutics, Inc. would be worth roughly what it owes.
Total debt $3.6M against a stock market value of $4.21B.
Distance to default 10.49 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 72.0%; Altman Z'' 13.74. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-06-16
Earliest Filing
2024-05-10
Latest Filing
partner: 2

Counterparties (Filed by EWTX)

2 relationships

Companies named in EWTX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Leerink Partners LLC — partner Entered into a Sales Agreement to act as sales agent for an ATM offering program. 2024-05-10 View
Cowen and Company, LLC — partner Former sales agent for at-the-market offering of common stock 2023-06-16 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-06 Earnings Release; Exhibits View
2026-07-16 Exhibits View
2026-07-13 Acquisition/Disposition; Regulation FD; Exhibits Acquisition View
2026-06-05 Shareholder Vote View
2026-06-01 Material Agreement; Exhibits Agreement View
2026-05-07 Earnings Release; Exhibits View
2026-02-26 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-20 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-11-10 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-11-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-08-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-06-26 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-05-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-02 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-04-02 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-03-03 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-22 Departure/Election of Directors; Appointment of Officers View
2024-12-16 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2024-11-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-08-12 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms